Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 1 hr 27 mins

S&P Futures
5,970.75
+12.50(+0.21%)
Dow Futures
43,963.00
+62.00(+0.14%)
Nasdaq Futures
20,960.75
+66.75(+0.32%)
Russell 2000 Futures
2,417.80
+12.00(+0.50%)
Crude Oil
70.89
-0.80(-1.12%)
Gold
2,679.70
+3.40(+0.13%)

International Stem Cell Corporation (ISCO)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD

Follow

0.1000

+0.0010

(+1.01%)

At close: 03:00PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	792.43k
Enterprise Value	3.62M
Trailing P/E	4.67
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.10
Price/Book (mrq)	N/A
Enterprise Value/Revenue	0.43
Enterprise Value/EBITDA	166.00

Trading Information

Stock Price History

Beta (5Y Monthly)	0.13
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	0.1500
52 Week Low ³	0.0500
50-Day Moving Average ³	0.0704
200-Day Moving Average ³	0.0830

Share Statistics

Avg Vol (3 month) ³	3k
Avg Vol (10 day) ³	5.86k
Shares Outstanding ⁵	8M
Implied Shares Outstanding ⁶	N/A
Float ⁸	3.7M
% Held by Insiders ¹	53.77%
% Held by Institutions ¹	0.00%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:150
Last Split Date ³	Jul 29, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	-8.22%
Operating Margin (ttm)	6.39%

Management Effectiveness

Return on Assets (ttm)	-6.04%
Return on Equity (ttm)	-185.37%

Income Statement

Revenue (ttm)	8.32M
Revenue Per Share (ttm)	1.04
Quarterly Revenue Growth (yoy)	26.60%
Gross Profit (ttm)	N/A
EBITDA	-356k
Net Income Avi to Common (ttm)	-467k
Diluted EPS (ttm)	-0.0600
Quarterly Earnings Growth (yoy)	-75.80%

Balance Sheet

Total Cash (mrq)	1.29M
Total Cash Per Share (mrq)	0.16
Total Debt (mrq)	4.11M
Total Debt/Equity (mrq)	1,447.54
Current Ratio (mrq)	0.76
Book Value Per Share (mrq)	-0.50

Cash Flow Statement

Operating Cash Flow (ttm)	53k
Levered Free Cash Flow (ttm)	2.38k